Retatrutide, or LY3437943, is an investigational GIPR/GLP-1R/GCGR triple agonist. This research-only overview explains its nomenclature, receptor profile, evidence timeline, current status, and analytical-documentation requirements.
What Is Retatrutide (LY3437943)? Research Overview
read more